BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37675995)

  • 1. Quantitative Analysis of Whole-Body MRI for Accessing the Degree of Diffuse Infiltration Patterns and Identifying High Risk Cases of Newly Diagnosed Multiple Myeloma.
    Sun M; Wang L; Wang C; Ma J; Wang W; Lin L; Ren C; Zhang Y; Cheng J
    J Magn Reson Imaging; 2024 Jun; 59(6):2035-2045. PubMed ID: 37675995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of Diffuse Infiltration Pattern in Multiple Myeloma From Hyperplastic Hematopoietic Bone Marrow: Qualitative and Quantitative Analysis Using Whole-Body MRI.
    Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Liu Y
    J Magn Reson Imaging; 2022 Apr; 55(4):1213-1225. PubMed ID: 34558141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Diffuse Bone Marrow Infiltration Pattern in Monoclonal Plasma Cell Diseases by Quantitative Whole-body Magnetic Resonance Imaging.
    Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Zhang S; Lin L
    Acad Radiol; 2022 Apr; 29(4):490-500. PubMed ID: 34362664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.
    Sun M; Cheng J; Ren C; Zhang Y; Li Y; Li Y; Zhang S
    Quant Imaging Med Surg; 2021 Aug; 11(8):3767-3780. PubMed ID: 34341748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
    Takasu M; Kondo S; Akiyama Y; Takahashi Y; Maeda S; Baba Y; Kawase T; Ichinohe T; Awai K
    PLoS One; 2020; 15(2):e0229607. PubMed ID: 32106239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients.
    Berardo S; Sukhovei L; Andorno S; Carriero A; Stecco A
    Radiol Med; 2021 Mar; 126(3):445-452. PubMed ID: 32812173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Body Low-Dose CT in Multiple Myeloma: Diagnostic Value of Appendicular Medullary Patterns of Attenuation.
    Koutoulidis V; Terpos E; Klapa I; Cheliotis G; Ntanasis-Stathopoulos I; Boultadaki A; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
    AJR Am J Roentgenol; 2021 Mar; 216(3):742-751. PubMed ID: 33439048
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
    Dong H; Huang W; Ji X; Huang L; Zou D; Hao M; Deng S; Shen Z; Lu X; Wang J; Song Z; Zhang X; Xue H; Xia S
    AJR Am J Roentgenol; 2022 Feb; 218(2):310-319. PubMed ID: 34523949
    [No Abstract]   [Full Text] [Related]  

  • 9. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
    D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
    AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent diffusion coefficient measurements of bone marrow infiltration patterns in multiple myeloma for the assessment of tumor burden - a feasibility study.
    Xiong X; Ma Y; Dai Y; Hu C; Zhang Y
    Radiol Oncol; 2023 Dec; 57(4):455-464. PubMed ID: 38038425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
    Chiabai O; Van Nieuwenhove S; Vekemans MC; Tombal B; Peeters F; Wuts J; Triqueneaux P; Omoumi P; Kirchgesner T; Michoux N; Lecouvet FE
    Eur Radiol; 2023 Jan; 33(1):244-257. PubMed ID: 35925384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bone marrow infiltration in multiple myeloma using whole-body diffusion-weighted imaging and T1-weighted water-fat separation Dixon.
    Ji X; Huang W; Dong H; Shen Z; Zheng M; Zou D; Shen W; Xia S
    Quant Imaging Med Surg; 2021 Feb; 11(2):641-651. PubMed ID: 33532264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histogram Analysis Based on Apparent Diffusion Coefficient Maps of Bone Marrow in Multiple Myeloma: An Independent Predictor for High-risk Patients Classified by the Revised International Staging System.
    Wang Q; Zhang L; Li S; Sun Z; Wu X; Zhao A; Benkert T; Zhou D; Xue H; Jin Z; Li J
    Acad Radiol; 2022 Jun; 29(6):e98-e107. PubMed ID: 34452820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
    Sommer G; Klarhöfer M; Lenz C; Scheffler K; Bongartz G; Winter L
    Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes.
    Yoo HJ; Hong SH; Kim DH; Choi JY; Chae HD; Jeong BM; Ahn JM; Kang HS
    J Magn Reson Imaging; 2017 May; 45(5):1534-1544. PubMed ID: 27690264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
    Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Hillengass M; Wagner B; Hose D; Raab MS; Jauch A; Delorme S; Goldschmidt H; Weber MA; Hillengass J
    Eur Radiol; 2016 Nov; 26(11):3939-3948. PubMed ID: 26767378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
    Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
    Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
    Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.